3/26
08:58 am
eftr
Form 10-K eFFECTOR Therapeutics, For: Dec 31
Low
Report
Form 10-K eFFECTOR Therapeutics, For: Dec 31
3/25
04:11 pm
eftr
Form 8-K eFFECTOR Therapeutics, For: Mar 25
Medium
Report
Form 8-K eFFECTOR Therapeutics, For: Mar 25
2/21
05:41 pm
eftr
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Loewy Caroline M
Low
Report
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Loewy Caroline M
2/21
05:28 pm
eftr
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Bhatt Elizabeth
Low
Report
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Bhatt Elizabeth
2/21
05:27 pm
eftr
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Ehrlich Christopher B
Low
Report
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Ehrlich Christopher B
2/21
05:24 pm
eftr
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Klencke Barbara
Low
Report
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Klencke Barbara
2/21
05:22 pm
eftr
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Harrington-Smith Kristen
Low
Report
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Harrington-Smith Kristen
2/21
05:17 pm
eftr
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Gallagher Brian M. Jr.
Low
Report
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Gallagher Brian M. Jr.
2/21
05:04 pm
eftr
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Byrnes Michael
Low
Report
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Byrnes Michael
2/21
05:03 pm
eftr
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Warner Douglas J
Low
Report
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: Warner Douglas J
2/21
04:58 pm
eftr
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: WORLAND STEPHEN T
Low
Report
Form 4 eFFECTOR Therapeutics, For: Feb 19 Filed by: WORLAND STEPHEN T
2/14
03:49 pm
eftr
Form SC 13G/A eFFECTOR Therapeutics, Filed by: PFIZER INC
Low
Report
Form SC 13G/A eFFECTOR Therapeutics, Filed by: PFIZER INC
2/14
09:49 am
eftr
Form SC 13G/A eFFECTOR Therapeutics, Filed by: SECTORAL ASSET MANAGEMENT INC
High
Report
Form SC 13G/A eFFECTOR Therapeutics, Filed by: SECTORAL ASSET MANAGEMENT INC
2/9
08:15 pm
eftr
Form SC 13G/A eFFECTOR Therapeutics, Filed by: SR ONE CAPITAL MANAGEMENT, LLC
Low
Report
Form SC 13G/A eFFECTOR Therapeutics, Filed by: SR ONE CAPITAL MANAGEMENT, LLC
2/5
04:15 pm
eftr
Form SC 13G/A eFFECTOR Therapeutics, Filed by: Altitude Life Science Ventures Fund II, L.P.
Low
Report
Form SC 13G/A eFFECTOR Therapeutics, Filed by: Altitude Life Science Ventures Fund II, L.P.
1/30
08:32 am
eftr
Form 8-K eFFECTOR Therapeutics, For: Jan 29
Medium
Report
Form 8-K eFFECTOR Therapeutics, For: Jan 29
1/26
04:40 pm
eftr
Form 8-K eFFECTOR Therapeutics, For: Jan 24
Medium
Report
Form 8-K eFFECTOR Therapeutics, For: Jan 24
1/26
04:32 pm
eftr
Form 424B5 eFFECTOR Therapeutics,
High
Report
Form 424B5 eFFECTOR Therapeutics,
1/10
08:06 am
eftr
Form 424B3 eFFECTOR Therapeutics,
Low
Report
Form 424B3 eFFECTOR Therapeutics,
1/10
08:02 am
eftr
Form 8-K eFFECTOR Therapeutics, For: Jan 09
Medium
Report
Form 8-K eFFECTOR Therapeutics, For: Jan 09
1/8
09:08 am
eftr
Form 424B3 eFFECTOR Therapeutics,
Low
Report
Form 424B3 eFFECTOR Therapeutics,
1/8
08:15 am
eftr
Form 8-K eFFECTOR Therapeutics, For: Jan 08
Low
Report
Form 8-K eFFECTOR Therapeutics, For: Jan 08